Medindia
Medindia LOGIN REGISTER
Advertisement

deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results

Wednesday, October 31, 2007 General News
Advertisement
REYKJAVIK, Iceland, Oct. 30 deCODE genetics,Inc. (Nasdaq: DCGN) today announced that it will report its third quarter 2007financial results in a press release to be issued on Monday, November 5, afterthe close of the market in New York. The company will host a live webcast ofits conference call to discuss these results and recent operating highlightson Tuesday, November 6, at 8am Eastern Standard Time/1 pm GMT.
Advertisement

The webcast can be accessed through the Investors page of deCODE'swebsite, www.decode.com, or through www.earnings.com. Please log in to thewebcast 15 minutes prior to the scheduled start of the call. The call will bearchived for at least a week on each site. For those unable to listen to thewebcast because of company firewall or other issues, a digitized audio replaywill also be available by telephone from approximately 11:30am EST on Tuesday,November 6 and for one week thereafter. The dial-in replay numbers are: 1(800) 475-6701 in the U.S., and +1 (320) 365-3844 for those calling fromoutside the U.S. The access code is 892864.
Advertisement

Any statements contained in this presentation that relate to future plans,events or performance are forward-looking statements within the meaning of thePrivate Securities Litigation Reform Act of 1995. These forward-lookingstatements are subject to a number of risks and uncertainties that could causeactual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others,those relating to technology and product development, integration of acquiredbusinesses, market acceptance, government regulation and regulatory approvalprocesses, intellectual property rights and litigation, dependence oncollaborative relationships, ability to obtain financing, competitiveproducts, industry trends and other risks identified in deCODE's filings withthe Securities and Exchange Commission. deCODE undertakes no obligation toupdate or alter these forward-looking statements as a result of newinformation, future events or otherwise.Contacts: deCODE genetics Berglind Olafsdottir +354 570 2393 [email protected]

SOURCE deCODE genetics, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close